Prostate Cancer

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now - Beyond the Abstract January 30, 2025

Radiotherapy and Theranostics: A Lancet Oncology Commission - Beyond the Abstract January 28, 2025

Development of an Orally Bioavailable CDK12/13 Degrader and Induction of Synthetic Lethality with AKT Pathway Inhibition - Beyond the Abstract January 28, 2025

Survival Outcomes and Recurrence Patterns Following Focal High-intensity Focused Ultrasound Treatment for Localized Prostate Cancer: Insights on Patient Selection and Lessons Learned - Beyond the Abstract January 28, 2025

Use of Placebo in Urologic Oncology Randomized Controlled Trials - Beyond the Abstract January 27, 2025

Update on PSMA-based Prostate Cancer Imaging - Beyond the Abstract January 23, 2025

Integrative Analysis of Ultra-Deep RNA-Seq Reveals Alternative Promoter Usage as a Mechanism of Activating Oncogenic Programmes During Prostate Cancer Progression - Beyond the Abstract January 22, 2025

Validation of an Artificial Intelligence-Based Prognostic Biomarker in Patients with Oligometastatic Castration-Sensitive Prostate Cancer - Beyond the Abstract January 22, 2025

Pesticides and Prostate Cancer Incidence and Mortality: An Environment-Wide Association Study - Beyond the Abstract January 22, 2025

Intratumoral Heterogeneity Drives Acquired Therapy Resistance in a Patient with Metastatic Prostate Cancer - Beyond the Abstract January 22, 2025

The Proteogenomics of Prostate Cancer Radioresistance - Beyond the Abstract January 21, 2025

The Prognostic Role of Pan-Immune Inflammation Value in Patients with Metastatic Castration Resistance Prostate Cancer Treated with Lutetium-177 (177Lu)-PSMA-617 - Beyond the Abstract January 21, 2025

Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection - Beyond the Abstract January 17, 2025

A Novel Machine Learning-Based Predictive Model of Clinically Significant Prostate Cancer and Online Risk Calculator - Beyond the Abstract January 17, 2025

Single Cell and Spatial Transcriptomics Highlight the Interaction of Club-like Cells with Immunosuppressive Myeloid Cells in Prostate Cancer - Beyond the Abstract January 17, 2025

Comparison of Posttherapy 4- and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer - Beyond the Abstract January 16, 2025

Identifying The Best Candidate for Focal Therapy: A Comprehensive Review - Beyond the Abstract January 15, 2025

[225Ac]Ac-PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis - Beyond the Abstract January 15, 2025

Anatomic Factors Associated with Complications after Radical Prostatectomy: A Systematic Review and Meta-analysis - Beyond the Abstract January 14, 2025

Increased Translation Driven by Non-Canonical EZH2 Creates a Synthetic Vulnerability in Enzalutamide-Resistant Prostate Cancer - Beyond the Abstract January 14, 2025

Page 1 of 60